SEC EDGAR · Company announcement
BWXT: Financial results
Filed 8-K for an event or period dated 2026-09-30. Financial results.
Follow BWXT- Became public
- Nov 2, 2026, 4:15 PM EST
- Event / period date
- Sep 30, 2026
- Collected
- Nov 7, 2026, 5:57 PM EST
Why this is connected
This filing identifies BWX Technologies, Inc. as the issuer of the security. The company's SEC identifier connects it to BWXT.
Earnings Release dated November 2, 2026. ↗Source evidence
Read the source excerpt or record
Item 2.02 Results of Operations and Financial Condition. On November 2, 2026, we issued a press release announcing our financial results for the third quarter ended September 30, 2026. A copy of the press release is attached as Exhibit 99.1, and the information contained in Exhibit 99.1 is incorporated by reference. The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Earnings Release dated November 2, 2026. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BWX TECHNOLOGIES, INC. By: /s/ Kevin J. Gorman Kevin J. Gorman Vice President and Chief Accounting Officer November 2, 2026
Congressional trading in BWXT
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 9, 2026$100K–$250K
Rep. April McClain Delaney (D-MD-6)
$100K–$250K · Traded Aug 25, 2026 · disclosed Sep 9, 2026 · Dependent
Committee overlap: Science - Sep 9, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Aug 3, 2026 · disclosed Sep 9, 2026 · Dependent
Committee overlap: Science - Aug 3, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 3, 2026 · Dependent
Committee overlap: ScienceTraded 4 days before earnings - Aug 3, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jul 27, 2026 · disclosed Aug 3, 2026 · Dependent
Committee overlap: ScienceTraded 7 days before earnings - Aug 3, 2026$15K–$50K
Rep. April McClain Delaney (D-MD-6)
$15K–$50K · Traded Jul 24, 2026 · disclosed Aug 3, 2026 · Dependent
Committee overlap: ScienceTraded 10 days before earnings - Jun 5, 2026$15K–$50K
Rep. April McClain Delaney (D-MD-6)
$15K–$50K · Traded May 15, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 14, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$15K–$50K
Rep. April McClain Delaney (D-MD-6)
$15K–$50K · Traded May 8, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.